GPC3 and hepatocellular carcinoma: El-Saadany et al. (2018) investigated the use of GPC-3 to aid in the diagnosis of HCC by comparing it to 20 healthy controls and two groups of 80 patients with α-FP less than or greater than 400 ng/mL.